Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 3/20 | 0.86 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.86 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL27892078 | 1.00 | CA5A (0.86) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL27435856 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL32912 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL14875685 | 0.94 | CA5A (0.75) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL979953 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL4638017 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL1506930 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL9051450 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL9296659 | 0.94 | CA5A (0.75) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL5267450 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114574637-A | Non-chromium tanning process based on POSS-COONa and non-chromium metal salt | 陕西科技大学 | 2022-06-03 | — | — | CN | disclosed |
| CN-111646888-A | Method for producing cosmetic perfume cedryl ketone | 李金国 | 2020-09-11 | — | — | CN | disclosed |
| US-10005718-B2 | Catalyst, and method for producing oxidation product | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-06-26 | — | — | US | disclosed |
| EP-2940004-B1 | METHOD FOR PRODUCING OXIME | SUMITOMO CHEMICAL CO (JP) | 2017-09-13 | — | — | EP | disclosed |
| US-9656950-B2 | Method for producing oxime | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-23 | — | — | US | disclosed |
| US-9533944-B2 | Method for producing oxime | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-01-03 | — | — | US | disclosed |
| EP-3103551-A1 | CATALYST, AND METHOD FOR MANUFACTURING OXIDATION PRODUCT | Sumitomo Chemical Company Limited (JP) | 2016-12-14 | — | — | EP | disclosed |
| US-20160347707-A1 | CATALYST, AND METHOD FOR PRODUCING OXIDATION PRODUCT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-12-01 | — | — | US | disclosed |
| US-9334211-B2 | Hydrocracking catalyst, method for producing same, and method for producing hydroxy compound using said catalyst | UBE INDUSTRIES, LTD. (JP) | 2016-05-10 | — | — | US | disclosed |
| US-20160075639-A1 | METHOD FOR PRODUCING OXIME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-03-17 | — | — | US | disclosed |
| EP-2980065-A1 | METHOD FOR PRODUCING OXIME | Sumitomo Chemical Company Limited (JP) | 2016-02-03 | — | — | EP | disclosed |
| US-20150353478-A1 | METHOD FOR PRODUCING OXIME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-12-10 | — | — | US | disclosed |
| EP-2940004-A1 | METHOD FOR PRODUCING OXIME | Sumitomo Chemical Company Limited (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-20140288335-A1 | HYDROCRACKING CATALYST, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING HYDROXY COMPOUND USING SAID CATALYST | UBE INDUSTRIES, LTD. (JP) | 2014-09-25 | — | — | US | disclosed |
| WO-2012085653-A1 | WATERPROOFING TREATMENT | BENELLI ALESSIO (IT) | 2012-06-28 | — | — | WO | disclosed |
| CN-1302290-A | Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions | INST ORCH SINTEZA URAL OTDEL R (RU) | 2001-07-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288335-A1 | HYDROCRACKING CATALYST, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING HYDROXY COMPOUND USING SAID CATALYST | HAO2, HMOX1, HMOX2 | CA5A 366/4885CA5B 267/4885TSHR 4510/4885 |
| US-20160347707-A1 | CATALYST, AND METHOD FOR PRODUCING OXIDATION PRODUCT | PPOX, HAO2, SCO2 | CA5A 145/4885CA5B 106/4885TSHR 3391/4885 |
| US-20150353478-A1 | METHOD FOR PRODUCING OXIME | HAO2, HMOX2, OXGR1 | CA5A 452/4885CA5B 417/4885TSHR 857/4885 |
| US-20160075639-A1 | METHOD FOR PRODUCING OXIME | HAO2, DUOX2, PPOX | CA5A 146/4885CA5B 161/4885TSHR 1487/4885 |
| US-10005718-B2 | Catalyst, and method for producing oxidation product | PPOX, HAO2, SCO2 | CA5A 145/4885CA5B 106/4885TSHR 3391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.